172 related articles for article (PubMed ID: 25227662)
1. Association of hOGG1 Ser326Cys polymorphism with colorectal cancer risk: an updated meta-analysis including 5235 cases and 8438 controls.
Zhang M; Mo R
Tumour Biol; 2014 Dec; 35(12):12627-33. PubMed ID: 25227662
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of the association between hOGG1 Ser326Cys polymorphism and risk of colorectal cancer based on case--control studies.
Guo CL; Han FF; Wang HY; Wang L
J Cancer Res Clin Oncol; 2012 Sep; 138(9):1443-8. PubMed ID: 22526153
[TBL] [Abstract][Full Text] [Related]
3. Association between the hOGG1 Ser326Cys polymorphism and lung cancer susceptibility: a meta-analysis based on 22,475 subjects.
Xu Z; Yu L; Zhang X
Diagn Pathol; 2013 Aug; 8():144. PubMed ID: 23971971
[TBL] [Abstract][Full Text] [Related]
4. The hOGG1 Ser326Cys polymorphism contributes to cancer susceptibility: evidence from 83 case-control studies.
Wang W; Wang M; Chen Y; Zhang Z; Wang S; Xu M; Wang B; Zhao Q; Zhang Z
Mutagenesis; 2012 May; 27(3):329-36. PubMed ID: 22121210
[TBL] [Abstract][Full Text] [Related]
5. An association between hOGG1 Ser326Cys polymorphism and the risk of bladder cancer in non-smokers: a meta-analysis.
Ji C; Liu Z; Chen H; Guo H; Liu C
BMC Cancer; 2012 Aug; 12():335. PubMed ID: 22857644
[TBL] [Abstract][Full Text] [Related]
6. Association of the hOGG1 Ser326Cys polymorphism with gynecologic cancer susceptibility: a meta-analysis.
Shi Y; Xu W; Zhang X
Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33210702
[TBL] [Abstract][Full Text] [Related]
7. A meta-analysis of the association between the hOGG1 Ser326Cys polymorphism and the risk of esophageal squamous cell carcinoma.
Zhang J; Zhou J; Zhang P; Wang W; Tao S; Wang M
PLoS One; 2013; 8(6):e65742. PubMed ID: 23762419
[TBL] [Abstract][Full Text] [Related]
8. Lack of association between hOGG1 Ser326Cys polymorphism and the risk of bladder cancer: a meta-analysis.
Li D; Liu H; Yan L; Tang Y; Ren J; Xu Z
Urol Int; 2012; 88(1):88-94. PubMed ID: 22156293
[TBL] [Abstract][Full Text] [Related]
9. Association of hOGG1 Ser326Cys polymorphism with gastric cancer risk: a meta-analysis.
Niu Y; Li F; Tang B; Shi Y; Yu P
Mol Biol Rep; 2012 Jun; 39(6):6563-8. PubMed ID: 22294108
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of excision repair gene XPD Lys751Gln and hOGG1 Ser326Cys might not be associated with hepatocellular carcinoma risk: a meta-analysis.
Zhang RC; Mou SH
Tumour Biol; 2013 Apr; 34(2):901-7. PubMed ID: 23271362
[TBL] [Abstract][Full Text] [Related]
11. No association between hOGG1 Ser326Cys polymorphism and hepatocellular carcinoma.
Zhen-Bo T; An-Lin F; Ling L; Su-Fang Z
Hepatogastroenterology; 2013; 60(125):1101-4. PubMed ID: 23186590
[TBL] [Abstract][Full Text] [Related]
12. The effect of hOGG1 Ser326Cys polymorphism on cancer risk: evidence from a meta-analysis.
Wei B; Zhou Y; Xu Z; Xi B; Cheng H; Ruan J; Zhu M; Hu Q; Wang Q; Wang Z; Yan Z; Jin K; Zhou D; Xuan F; Huang X; Shao J; Lu P
PLoS One; 2011; 6(11):e27545. PubMed ID: 22114677
[TBL] [Abstract][Full Text] [Related]
13. Human 8-oxoguanine DNA glycosylase gene polymorphism (Ser326Cys) and cancer risk: updated meta-analysis.
Kang SW; Kim SK; Park HJ; Chung JH; Ban JY
Oncotarget; 2017 Jul; 8(27):44761-44775. PubMed ID: 28415770
[TBL] [Abstract][Full Text] [Related]
14. Association between the OGG1 Ser326Cys and APEX1 Asp148Glu polymorphisms and lung cancer risk: a meta-analysis.
Wei W; He XF; Qin JB; Su J; Li SX; Liu Y; Zhang Y; Wang W
Mol Biol Rep; 2012 Dec; 39(12):11249-62. PubMed ID: 23065211
[TBL] [Abstract][Full Text] [Related]
15. hOGG1 Ser326Cys polymorphism and lung cancer susceptibility: a meta-analysis.
Geng P; Yao J; Zhu Y
Mol Biol Rep; 2014; 41(4):2299-306. PubMed ID: 24435978
[TBL] [Abstract][Full Text] [Related]
16. The hOGG1 Ser326Cys polymorphism and breast cancer risk: a meta-analysis.
Yuan W; Xu L; Feng Y; Yang Y; Chen W; Wang J; Pang D; Li D
Breast Cancer Res Treat; 2010 Aug; 122(3):835-42. PubMed ID: 20058067
[TBL] [Abstract][Full Text] [Related]
17. The hOGG1 Ser326Cys polymorphism and prostate cancer risk: a meta-analysis of 2584 cases and 3234 controls.
Zhang H; Xu Y; Zhang Z; Li L
BMC Cancer; 2011 Sep; 11():391. PubMed ID: 21914193
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis demonstrates lack of association of the hOGG1 Ser326Cys polymorphism with bladder cancer risk.
Zhong DY; Chu HY; Wang ML; Ma L; Shi DN; Zhang ZD
Genet Mol Res; 2012 Sep; 11(3):3490-6. PubMed ID: 23079842
[TBL] [Abstract][Full Text] [Related]
19. Association of the hOGG1 Ser326Cys polymorphism with increased lung cancer susceptibility in Asians: a meta-analysis of 18 studies including 7592 cases and 8129 controls.
Guan P; Huang D; Yin Z; Zhou B
Asian Pac J Cancer Prev; 2011; 12(4):1067-72. PubMed ID: 21790253
[TBL] [Abstract][Full Text] [Related]
20. Lack of association between the hOGG1 Ser326Cys polymorphism and gastric cancer risk: a meta-analysis.
Li BR; Zhou GW; Bian Q; Song B
Asian Pac J Cancer Prev; 2012; 13(4):1145-9. PubMed ID: 22799296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
